EGFR and lung cancer: Lung adenocarcinoma (LUAD) is the main histological subtype of lung cancer, and approximately 40% of Asian patients with LUAD carry activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) [2–4].